Galapagos NV
GLPG Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Income
Balance Sheet
Cash Flow
GLPG Income Statement
GLPG Balance Sheet
GLPG Cash Flow
Recent trades of GLPG by members of U.S. Congress
GLPG Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
GLPG Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
GLPG Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by GLPG's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
U.S. Patents
New patents grants
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of diseases Aug. 20, 2024
-
Patent Title: Pharmaceutical compositions comprising a jak inhibitor May. 07, 2024
-
Patent Title: 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis Aug. 08, 2023
-
Patent Title: Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jun. 06, 2023
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jan. 31, 2023
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of diseases May. 24, 2022
-
Patent Title: Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jan. 11, 2022
-
Patent Title: Pyrrolopyrimidine and pyrrolopyridine derivatives Oct. 05, 2021
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jul. 27, 2021
-
Patent Title: Compound useful for the treatment of degenerative and inflammatory diseases May. 11, 2021
-
Patent Title: 5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis Mar. 09, 2021
-
Patent Title: Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders Feb. 16, 2021
-
Patent Title: 5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts 4 and 5 inhibitors for treating e.g. osteoarthritis Nov. 10, 2020
-
Patent Title: Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jul. 07, 2020
-
Patent Title: Dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders Feb. 25, 2020
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Feb. 25, 2020
-
Patent Title: 5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts 4 and 5 inhibitors for treating e.g. osteoarthritis Feb. 04, 2020
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jan. 07, 2020
-
Patent Title: 6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-b]pyridin-3-yl]-nicotinonitrile derivatives and their use as irak inhibitors Dec. 17, 2019
-
Patent Title: Pharmaceutical compositions for the treatment of inflammatory disorders Dec. 03, 2019
-
Patent Title: 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis Nov. 26, 2019
-
Patent Title: Methods for the treatment of cardiovascular disorders Aug. 13, 2019
-
Patent Title: Compound useful for the treatment of degenerative and inflammatory diseases Jun. 25, 2019
-
Patent Title: Compounds useful for the treatment of degenerative and inflammatory diseases Feb. 19, 2019
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jan. 15, 2019
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Nov. 13, 2018
-
Patent Title: Molecular targets and compounds, and methods to identify the same, useful in the treatment of fibrotic diseases Aug. 14, 2018
-
Patent Title: Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders Aug. 14, 2018
-
Patent Title: Compound useful for the treatement of degenerative and inflammatory diseases Jun. 05, 2018
-
Patent Title: Methods of identifying compounds for the treatment of fibrosis by using s1pr5 Apr. 24, 2018
-
Patent Title: Methods and means for treatment of osteoarthritis Apr. 24, 2018
-
Patent Title: Methods for identifying compounds that inhibit g protein-coupled receptor (gpr84) agonist-stimulated chemotaxis Apr. 17, 2018
-
Patent Title: 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis Mar. 27, 2018
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Feb. 20, 2018
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Jan. 16, 2018
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Oct. 24, 2017
-
Patent Title: Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders (gpr84 antagonists) Jul. 18, 2017
-
Patent Title: Compound useful for the treatment of degenerative and inflammatory diseases Jul. 18, 2017
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jun. 06, 2017
-
Patent Title: Compound useful for the treatment of degenerative and inflammatory diseases Nov. 29, 2016
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Sep. 13, 2016
-
Patent Title: Compounds useful for the treatment of degenerative and inflammatory diseases Aug. 16, 2016
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Jul. 05, 2016
-
Patent Title: Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jul. 05, 2016
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis May. 31, 2016
-
Patent Title: Compound useful for the treatment of degenerative and inflammatory diseases Apr. 12, 2016
-
Patent Title: Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof Mar. 15, 2016
-
Patent Title: Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders Feb. 09, 2016
-
Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Feb. 02, 2016
-
Patent Title: Compound useful for the treatment of degenerative and inflammatory diseases Jan. 26, 2016
Government Contracts
Federal grants, loans, and purchases
Government Contracts
Estimated quarterly amount awarded from public contracts
WallStreetBets
Number of mentions of GLPG in WallStreetBets Daily Discussion
GLPG News
Recent insights relating to GLPG
CNBC Recommendations
Recent picks made for GLPG stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in GLPG
GLPG Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view GLPG Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More